Steven E. Abelman is listed as a director on 3 SEC Form D filings by 1 issuer between Jun 2024 and Mar 2025: BioSig Technologies, Inc. (Los Angeles, CA — other health care — 2024–2025; $8.62M reported sold to 107 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 7 court cases matching the name, 6 bankruptcy cases matching the name listed in Key records below.
What this means 13 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Steven E. Abelman and found 4 differences: Form D filed 21 days after the first sale; Form D filed 36 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.